Besiktas, Turkey

Gurbet Cacan

This inventor holds 5 USPTO granted patents. Top assignee: Bahçesehir Üniversitesi. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gurbet Cacan. Retrieved from https://idiyas.com/inventor/gurbet-cacan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gurbet Cacan

Introduction

Gurbet Cacan is a notable inventor based in Besiktas, Istanbul, Turkey. He has made significant contributions to the field of therapeutic compounds, particularly in the development of BCL-2 inhibitors. With a total of five patents to his name, Cacan's work is recognized for its potential impact on medical science.

Latest Patents

Cacan's latest patents include a physics-driven discovery of novel small therapeutic compounds for use as BCL-2 inhibitors. The invention relates to a compound shown with a specific formula, or a pharmaceutically acceptable derivative thereof, aimed at serving as a novel inhibitor of BCL-2. This innovative approach highlights the intersection of physics and pharmacology in developing new therapeutic options.

Career Highlights

Cacan is affiliated with Bahcesehir Universitesi, where he continues to advance his research and innovation in the field. His academic and professional journey reflects a commitment to exploring new frontiers in therapeutic development.

Collaborations

Cacan has collaborated with notable colleagues, including Muge Didem Orhan and Berna Dogan. These partnerships enhance the collaborative spirit of research and innovation in his work.

Conclusion

Gurbet Cacan's contributions to the field of therapeutic compounds and his innovative patents position him as a significant figure in medical research. His work continues to inspire advancements in the development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…